AbCellera Biologics Inc. (NASDAQ:ABCL) Receives Average Rating of “Moderate Buy” from Brokerages
Shares of AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) have received a consensus rating of “Moderate Buy” from the ten brokerages that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average twelve-month target […]
More Stories
Vuzix Corporation Grants Restricted Stock Units to Key Executives
Vuzix Corporation (NASDAQ: VUZI) announced in an 8-K filing dated January 2, 2025, that it has granted restricted stock units...
CEMIG (NYSE:CIG) Downgraded to “Hold” Rating by HSBC
HSBC downgraded shares of CEMIG (NYSE:CIG – Free Report) from a buy rating to a hold rating in a research...
Amazon.com (NASDAQ:AMZN) Trading 0% Higher – Still a Buy?
Amazon.com, Inc. (NASDAQ:AMZN) shares traded up 0% during mid-day trading on Thursday . The stock traded as high as $223.52...
Insmed Incorporated (NASDAQ:INSM) COO Roger Adsett Sells 4,902 Shares of Stock
Insmed Incorporated (NASDAQ:INSM – Get Free Report) COO Roger Adsett sold 4,902 shares of Insmed stock in a transaction that...
Insmed Incorporated (NASDAQ:INSM) CFO Sara Bonstein Sells 3,470 Shares
Insmed Incorporated (NASDAQ:INSM – Get Free Report) CFO Sara Bonstein sold 3,470 shares of Insmed stock in a transaction on...
Analyzing Maximus (NYSE:MMS) & International Monetary Systems (OTCMKTS:ITNM)
Maximus (NYSE:MMS – Get Free Report) and International Monetary Systems (OTCMKTS:ITNM – Get Free Report) are both business services companies,...